INTRODUCTION {#S1}
============

*MYC* encodes a transcription factor that, through the regulation of its target genes, promotes cell growth and malignant transformation. Overexpression or amplification of this gene and the consequent aberrant activation of the MYC transcriptional program are oncogenic events that occur frequently in diverse types of cancer ([@R21]). Under normal physiologic conditions, *MYC* expression and activity are tightly regulated at all levels of gene expression, from the controlled induction of its transcription ([@R39]) to the continuous degradation of MYC protein ([@R18]; [@R74]). Accordingly, robust post-transcriptional regulation governs the stability and translation of the *MYC* mRNA, the cues for which are encoded within the well-conserved untranslated regions (UTRs) of the transcript ([@R13]; [@R20]; [@R61]; [@R91]).

In eukaryotes, initiation of translation is a highly regulated process that begins with recruitment of the pre-initiation complex (PIC), comprising the 40S small ribosomal subunit, initiator tRNA, and several eukaryotic initiation factors (eIFs), to the 5′ cap. The PIC then scans the transcript in a 5′ to 3′ direction for a codon in the optimal context for initiation ([@R36]; [@R53]). As the PIC traverses the 5′ UTR, this region of the transcript can potently affect the location and rate of translation initiation ([@R28]). For instance, many 5′ UTRs harbor non-canonical initiation codons that are engaged at lower frequencies or only under specific contexts, whose use can produce a new protein or have effects on translation of the downstream canonical open reading frame (ORF) ([@R37]; [@R83]; [@R84]). The *MYC* 5′ UTR, for example, contains a suboptimal CUG initiation codon upstream of the canonical AUG, which, when engaged, leads to the production of an N-terminally extended isoform of the protein ([@R25]). Such alternatively initiated proteins often have properties and functions that are distinct from their canonically initiated counterparts and add diversity to the repertoire of proteins within a cell ([@R82]). It has been suggested that the MYC N-terminal extension influences the preferred transcriptional targets of the protein ([@R5]; [@R26]; [@R70]). A similar configuration exists on other notable mRNAs, such as *PTEN,* in which the use of upstream non-canonical initiation codons produces proteins that adopt different functions, including regulating energy metabolism in mitochondria and influencing PI3K signaling as a secreted protein ([@R30]; [@R48], [@R47]; [@R87]).

The mechanisms that regulate alternative start codon selection are not fully understood. The classic model of translation initiation proposes that a scanning PIC will pause at an initiator codon in an appropriate sequence context, triggering a series of events that culminate in large subunit joining and formation of an elongation-competent ribosome ([@R27]). Stabilization of the PIC at a start codon can be influenced by several factors, including the initiator tRNA, initiation factors, and/or RNA elements within the 5′ UTR. Modulation of any of these determinants of translation initiation can alter start codon choice and either promote, or impede, the use of suboptimal start codons ([@R3]; [@R37]; [@R83]). For example, an inhibitor of the translation initiation factor eIF5, known as eIF5-mimic protein 1 (5MP1; encoded by the *BZW2* gene), is overexpressed in colorectal cancer and promotes the use of the *MYC* AUG initiation codon, an event that has been proposed to enhance tumorigenesis in this setting ([@R70]).

eIF5A (not to be confused with the unrelated protein eIF5 mentioned above) is a highly conserved translation factor whose molecular function has been studied extensively in yeast. Despite being initially classified as an initiation factor, it is now understood to function primarily during translation elongation as a ribosomal pause relief factor, facilitating peptide bond formation at sites at which the peptidyl transfer reaction occurs inefficiently ([@R14]; [@R23]; [@R40]; [@R64]; [@R67]; [@R72]). eIF5A is the eukaryotic homolog of prokaryotic elongation factor P (EF-P) ([@R2]), which also functions to suppress ribosomal pausing. For example, proline-proline (PP) peptide bonds are dependent on eIF5A (or EF-P in bacteria) for their efficient synthesis because this amino acid is a poor substrate for peptide bond formation due to its sterically constrained cyclic ring side chain ([@R16]; [@R24]; [@R79]; [@R88]). A distinctive property of eIF5A is that it is the only known protein to contain the amino acid hypusine, a basic amino acid that is derived from the polyamine biosynthesis pathway and that is post-translationally incorporated into the protein by modification of a lysine residue ([@R12]; [@R15]). Despite detailed characterization of the role of eIF5A in translation in yeast and EF-P in prokaryotes, the role of mammalian eIF5A in translation is not well understood, in part because of the technical difficulties of depleting this essential protein ([depmap.org](http://depmap.org); [@R54]; [@R60]; [@R71]).

In this study, we initially set out to genetically dissect mechanisms of post-transcriptional regulation of the *MYC* 5′ UTR, given the prominent role of this protein in tumorigenesis and its tight regulation under physiologic conditions. Through a fluorescent reporter-coupled genome-scale CRISPR/Cas9-mediated loss-of-function screen, we unexpectedly uncovered a role for eIF5A as a regulator of *MYC* translation initiation codon selection. Loss of eIF5A resulted in enhanced use of the upstream *MYC* CUG start codon. Through ribosome profiling experiments in cells depleted of eIF5A, we demonstrated that this increase in the use of upstream alternative start codons was not unique to *MYC* and occurred broadly throughout the human and yeast transcriptomes. Moreover, we established that the function of eIF5A as a ribosomal pause relief factor is conserved in human cells. Indeed, our findings suggest that ribosomal pausing immediately downstream of alternative initiation sites, an event promoted by depletion of eIF5A, triggers ribosome queuing and, consequently, increased use of upstream start codons on *MYC* and other transcripts. Thus, we propose that eIF5A is a translation elongation factor that also performs an essential function in maintaining appropriate start codon selection.

RESULTS {#S2}
=======

A Genome-Scale Loss-of-Function Screen Identifies eIF5A as a Regulator of *MYC* Translation Initiation Codon Selection {#S3}
----------------------------------------------------------------------------------------------------------------------

In order to study post-transcriptional regulation conferred by the *MYC* 5′ UTR, we generated reporter constructs in which a constitutive promoter drives expression of an *EGFP*-encoding transcript that either contained or lacked the *MYC* 5′ UTR ([Figure 1A](#F1){ref-type="fig"}). These constructs were integrated into a defined locus (*AAVS1/PPP1R12C*) at single copy in the stably diploid human colon cancer cell line HCT116 to generate clonal *MYC* 5′ UTR and *EGFP* control reporter cell lines. Consistent with literature indicating that the *MYC* UTRs harbor repressive regulatory cues ([@R20]; [@R61]), cells expressing the 5′ UTR reporter construct were approximately 5 times dimmer than *EGFP* control reporter cells, as indicated by flow cytometry ([Figure 1B](#F1){ref-type="fig"}). We therefore designed a genome-scale CRISPR/Cas9-mediated loss-of-function screen to identify the genes that mediate repression of the 5′ UTR reporter ([Figure 1A](#F1){ref-type="fig"}).

CRISPR/Cas9 screening was carried out in both *MYC* 5′ UTR and *EGFP* control reporter cell lines as previously described ([@R22]). Briefly, reporter cells were transduced with a lentiviral library at a low MOI to deliver Cas9 and single guide RNAs (sgRNAs) targeting more than 19,000 human genes, resulting in the generation of a pool of single gene knockouts. Fluorescence-activated cell sorting (FACS) was then used to isolate the brightest cells, thereby enriching for those with impaired repression of the *MYC* 5′ UTR. Finally, next-generation sequencing was used to detect sgRNAs that were enriched in the sorted versus the unsorted populations, leading to the identification of genes whose loss of function increased fluorescence in the *MYC* 5′ UTR reporter, but not the *EGFP* control reporter, cell line.

Analysis of the screening data revealed that chromatin modifiers (*ASH2L, BRD4*) and general transcription factors and coactivators (*TAF1, TAF5, TAF7, CREBBP*) that would be expected to regulate transcription of the reporter constructs were recovered as significant hits in both *MYC* 5′ UTR and *EGFP* control reporter screens ([Figure S1A](#SD1){ref-type="supplementary-material"}). On the basis of a stringent statistical cutoff, four genes were identified as 5′ UTR-specific hits: translation factors *EIF5A/EIF5AL1* (enriched sgRNAs targeted both genes that encode nearly identical proteins) and *EIF3L,* the intron lariat debranching enzyme *DBR1,* and miR-889. Validation of screening results, performed by lentiviral delivery of Cas9 and individual sgRNAs, confirmed that *EIF5A/EIF5AL1* and *EIF3L* loss of function increased fluorescence of the *MYC* 5′ UTR reporter cells compared with the *EGFP* control cell line ([Figure S1B](#SD1){ref-type="supplementary-material"}), while loss of *DBR1* and miR-889 did not (data not shown). These data indicated that these translation factors were putative regulators of the *MYC* 5′ UTR and prompted us to investigate their effects on endogenous *MYC*.

Despite increasing EGFP fluorescence in a *MYC* 5′ UTR-specific manner, sgRNAs targeting *EIF3L* did not alter steady-state MYC protein levels in HCT116 cells ([Figure S1C](#SD1){ref-type="supplementary-material"}). It is possible that an effect on endogenous MYC was masked by the multiple redundant mechanisms that regulate MYC abundance, and therefore examination of the *EIF3L-MYC* interaction in other cellular contexts is warranted. Nevertheless, here we chose to focus on the top hit from the screen, *EIF5A/EIF5AL1*. Notably, significantly enriched sgRNAs in the screen targeted both *EIF5A* and its processed pseudogene *EIF5AL1,* which encodes a nearly identical protein. Importantly, *EIF5AL1* was not expressed in HCT116 cells ([Figure S1D](#SD1){ref-type="supplementary-material"}), and sgRNAs that selectively target *EIF5A* were sufficient to deplete the protein, while those selectively targeting *EIF5AL1* had no effect on protein levels ([Figure S1E](#SD1){ref-type="supplementary-material"}). Thus, *EIF5A* is the relevant eIF5A-encoding gene in this cell line.

Although eIF5A is an essential protein in eukaryotic cells ([depmap.org](http://depmap.org); [@R54]; [@R60]; [@R71]), lentiviral delivery of CRISPR components produced cell populations with nearly complete loss of detectable eIF5A protein ([Figure 1C](#F1){ref-type="fig"}). This resulted in a surprising effect on endogenous MYC protein in multiple cell lines, specifically, enhanced production of a larger protein isoform, termed MYC1, initiated from a non-canonical CUG initiation codon in the *MYC* 5′ UTR ([Figures 1C](#F1){ref-type="fig"}--[1E](#F1){ref-type="fig"} and [S1F](#SD1){ref-type="supplementary-material"}). We confirmed that the more slowly migrating MYC isoform is indeed the N-terminally extended MYC1 protein by introducing a sgRNA that targeted the MYC1 initiation codon ([Figures S2A](#SD1){ref-type="supplementary-material"} and [S2B](#SD1){ref-type="supplementary-material"}). As expected, this resulted in a loss of the larger MYC protein isoform in the presence or absence of *EIF5A*-targeting small interfering RNAs (siRNAs) ([Figure S2C](#SD1){ref-type="supplementary-material"}).

Hypusine, or hydroxyputrescine-lysine, is synthesized by the polyamine biosynthesis pathway and post-translationally incorporated into eIF5A, replacing lysine 50 in the protein ([@R59]). Knockout of deoxyhypusine hydrolase (*DOHH)*, which catalyzes the terminal step in this pathway, phenocopied the loss of eIF5A and resulted in enhanced production of MYC1 ([Figures 1F](#F1){ref-type="fig"}, [1G](#F1){ref-type="fig"}, and [S1F](#SD1){ref-type="supplementary-material"}). Depletion of DOHH significantly reduced hypusine-modified but not total eIF5A levels ([Figure 1F](#F1){ref-type="fig"}), indicating that the hypusine-modified form of eIF5A functions to regulate use of the non-canonical *MYC* initiation codon. Importantly, *MYC* mRNA levels and polysome association ([Figures S2D](#SD1){ref-type="supplementary-material"}--[S2F](#SD1){ref-type="supplementary-material"}), as well as MYC1 and MYC2 protein stability ([Figure S2G](#SD1){ref-type="supplementary-material"}), were not significantly altered upon genetic ablation of *EIF5A* or *DOHH*. Overall, these data reveal that hypusine-modified eIF5A functions as a regulator of non-canonical translation initiation in the *MYC* 5′ UTR.

Given that the predominant effect of loss of eIF5A on endogenous *MYC* was altered translation initiation codon selection, it was surprising that eIF5A depletion resulted in an increase in fluorescence of the *MYC* 5′ UTR *EGFP* reporter. We speculate that the discrepant behavior of the reporter and endogenous *MYC* may arise from a difference in reliance upon eIF5A for efficient translation of the *EGFP* and *MYC* ORFs. As shown below, eIF5A is required for efficient translation of PP and proline-glycine (PG) dipeptides. The *MYC* coding sequence has six such ribosomal pause sites, while *EGFP* has none. Thus, it is expected that efficient translation of *MYC,* but not *EGFP,* would be highly dependent upon eIF5A activity, offering a mechanistic explanation for why an increase in expression of the reporter does not correspond to an increase in endogenous MYC protein levels. Nevertheless, for the purposes of this study, rather than further investigating the behavior of the reporter system, we chose to focus our subsequent efforts on dissecting the role of eIF5A in regulating endogenous *MYC* and other transcripts. Ultimately, as shown below, this allowed us to generate new reporters that more accurately recapitulated the behavior of endogenous *MYC*.

eIF5A Relieves Ribosomal Pausing at PP and PG Dipeptides during Translation Elongation in Human Cells {#S4}
-----------------------------------------------------------------------------------------------------

In order to determine whether eIF5A regulates translation initiation more broadly across the transcriptome, we performed ribosome profiling under eIF5A loss-of-function conditions. Ribosome profiling experiments provide a snapshot of the position of ribosomes on mRNAs across the transcriptome, enabling the visualization of elongating ribosomes, as well as ribosomes that are stalled on transcripts ([@R6]; [@R33]). Pools of *EIF5A* and *DOHH* knockout HCT116 cells were generated using two independent sgRNAs per gene. Upon mapping of ribosome footprints to the human transcriptome, a clear periodicity of reads was observed ([Figure S3](#SD1){ref-type="supplementary-material"}), consistent with the movement of ribosomes along a transcript one codon at a time and indicating the generation of a high-quality ribosome profiling dataset.

In bacteria and yeast, eIF5A homologs have been demonstrated to relieve ribosomal pausing at inefficiently translated peptide sequences, the most prominent of these being PP dipeptides ([@R64]; [@R72]; [@R90]). Thus, we first examined our ribosome profiling dataset to assess whether this function of eIF5A is conserved in human cells. Indeed, we observed that transcripts containing two or more PP dipeptide sequences exhibited increased ribosome occupancy upon loss of eIF5A or DOHH, consistent with an increase in stalled ribosomes on these mRNAs ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). In order to directly visualize whether ribosome occupancy is increased at PP sites, we generated meta-codon plots in which transcriptome-wide ribosome occupancy on PP codons and their surrounding sequences within mRNAs were visualized. A clear increase in ribosome occupancy at PP dipeptides in *EIF5A* and *DOHH* knockout cells was observed ([Figure 2C](#F2){ref-type="fig"}), demonstrating that hypusine-modified eIF5A functions to relieve ribosomal pausing at these sequences in human cells.

Recent evidence from yeast demonstrates that several additional peptide motifs, beyond polyproline sequences, may also require eIF5A for efficient peptide bond formation ([@R64]; [@R72]). A *de novo* motif analysis was therefore performed to identify tripeptide sequences that exhibit increased ribosome occupancy in *EIF5A* or *DOHH* knockout cells ([Figures 2D](#F2){ref-type="fig"}--[2F](#F2){ref-type="fig"}). The tripeptide sequences at which ribosomes are most likely to stall in the absence of eIF5A or DOHH show an overrepresentation of PP and PG residues, consistent with previously reported ribosomal stalling sequences in yeast and bacteria ([@R16]; [@R63]; [@R64]; [@R72]; [@R90]). Additional amino acids were also highly represented, with proline-aspartic acid (PD) dipeptides and several tryptophan-containing motifs among the most enriched ([Figure 2F](#F2){ref-type="fig"}). Visualizing ribosome occupancy at the most highly enriched tripeptide stall motifs identified in the human dataset and their surrounding sequences through a meta-codon plot confirmed that pausing is enhanced at these sites in *EIF5A* or *DOHH* knockout cells ([Figure 2G](#F2){ref-type="fig"}). Collectively, these data demonstrate that the role of eIF5A in relieving ribosomal pausing during translation elongation is conserved from bacteria and yeast to humans.

Loss of Function of eIF5A Increases Upstream Translation Initiation {#S5}
-------------------------------------------------------------------

Loss of hypusine-modified eIF5A resulted in enhanced upstream translation initiation on the *MYC* mRNA at a non-canonical start codon. To investigate whether this occurs more broadly throughout the transcriptome, we examined upstream translation within the 5′ UTRs of transcripts in both yeast and human cells depleted of eIF5A using previously published ribosome profiling data ([@R72]) and the data generated in this study. Analysis of data from eIF5A-depleted yeast revealed a dramatic increase in upstream translation of transcripts that fulfilled minimal coverage cutoffs for reliably detectable 5′ UTR translation ([Figure 3A](#F3){ref-type="fig"}). These genes included classically studied genes known to harbor upstream ORFs (uORFs) such as *GCN4, CPA1*, and *HAP4* ([@R92]; [Figures 3B](#F3){ref-type="fig"} and [S4A](#SD1){ref-type="supplementary-material"}; [Table S1](#SD2){ref-type="supplementary-material"}).

We next examined ribosome profiling data from HCT116 cells to assess whether similar effects were detectable in human cells. A global increase in upstream translation in eIF5A- or DOHH-depleted cells was not observed ([Figures 3C](#F3){ref-type="fig"} and [S4B](#SD1){ref-type="supplementary-material"}). Instead, 5′ UTR translation was enhanced in a subset of genes that included *MYC* and other transcripts such as *PLOD3* and *CCDC94* ([Figures 3D](#F3){ref-type="fig"}, [3E](#F3){ref-type="fig"}, and [S4C](#SD1){ref-type="supplementary-material"}). In total, 295 of 3,447 genes that fulfilled minimal coverage requirements for reliable detection showed at least a 2-fold increase in 5′ UTR translation in *EIF5A* knockout cells ([Table S2](#SD3){ref-type="supplementary-material"}).

An examination of the genes whose upstream translation is increased in eIF5A-depleted cells revealed an overrepresentation of genes associated with the response to cellular stress in both human and yeast ribosome profiling datasets ([Figure S4D](#SD1){ref-type="supplementary-material"}). Activation of the eukaryotic integrated stress response (ISR) pathway, which coordinates the cellular response to diverse stress stimuli and whose defining feature is phosphorylation of eIF2α on serine 51, is known to broadly induce upstream translation ([@R1]; [@R80]). We therefore assessed whether loss of hypusine-modified eIF5A activated the ISR, which could account for the observed increase in 5′ UTR translation. Accumulation of phosphorylated eIF2α, however, was not observed in *EIF5A*^−/−^ or *DOHH*^−/−^cells ([Figure S4E](#SD1){ref-type="supplementary-material"}), demonstrating that regulation of upstream translation by eIF5A is independent of the ISR pathway. Because transcripts whose translation is activated by the ISR are enriched for upstream initiation codons and uORFs, this class of genes may be particularly reliant upon eIF5A activity to suppress 5′ UTR translation under non-stress conditions.

Loss of eIF5A Promotes Upstream Translation Initiation in the 5′ UTR of *PLOD3* {#S6}
-------------------------------------------------------------------------------

As an initial validation of the ribosome profiling data, we designed reporter constructs to assess non-canonical translation initiation in the 5′ UTR of *PLOD3,* a transcript that exhibited upstream translation in *EIF5A*^−/−^ and *DOHH*^−/−^ cells ([Figure 3E](#F3){ref-type="fig"}; [Table S2](#SD3){ref-type="supplementary-material"}). Because the *PLOD3* 5′ UTR has multiple potential upstream initiation codons (AUG or single nucleotide variants thereof) in all three reading frames, we designed three separate reporters in which a P2A-luciferase sequence was fused to the 5′ UTR and the proximal segment of the *PLOD3* ORF in all three reading frames (with all potential stop codons removed), with the canonical AUG initiation codon mutated or frameshifted. Luciferase activity was normalized to translation of a reporter that initiated translation at the canonical *PLOD3* AUG start codon. Consistent with the ribosome profiling analysis, increased upstream translation initiation in all three reading frames, but particularly in frame 3, was observed in *EIF5A*^−/−^ cells ([Figure 3F](#F3){ref-type="fig"}).

Ribosomal Pausing Promotes Increased Use of the MYC1 Initiation Codon {#S7}
---------------------------------------------------------------------

Given that the principal effect of eIF5A depletion is increased ribosomal pausing at difficult to translate peptide motifs, we hypothesized that increased 5′ UTR translation under these conditions could be a consequence of inefficient translation elongation. Multiple observations supported this concept. First, it was recently reported that ribosomal pausing in the 5′ UTR of the mouse *Azin1* mRNA promoted non-canonical translation initiation within a short distance upstream of the pause site ([@R35]). The authors proposed that this enhanced alternative initiation could be attributed to the queuing of scanning ribosomes upstream of a paused ribosome, resulting in the enhanced positioning of ribosomes at a non-canonical initiation codon. This model is further supported by the demonstration that ribosome stalling induced by a stable RNA secondary structure downstream of a weak translation initiation site enhanced upstream initiation ([@R42]; [@R48]). Similarly, protein synthesis inhibitors that impair ribosome elongation enhance the use of non-canonical start codons ([@R38]). Interestingly, we noticed that a strong ribosomal pause motif (PPA) is located between the MYC1 and MYC2 initiation sites on the *MYC* transcript ([Figure 4A](#F4){ref-type="fig"}). Thus, we postulated that ribosome stalling in the *MYC* leader sequence may promote enhanced use of the MYC1 translation initiation site upon eIF5A loss of function.

To test this model, luciferase constructs that report MYC1 translation were generated ([Figure 4B](#F4){ref-type="fig"}). These constructs consisted of a fragment of the *MYC* transcript beginning upstream of the MYC1 initiation codon and extending into the body of the *MYC* ORF followed by a P2A-luciferase sequence. To specifically measure MYC1-initiated translation, the canonical MYC2 AUG initiation codon was mutated to UUU. Control constructs in which the MYC1 CUG initiation codon was mutated to AUG were also generated. Normalization of the luciferase signal produced by CUG-initiated constructs to the signal produced by AUG-initiated derivatives ensured that only the efficiency of non-canonical initiation was measured, and any effects on translation elongation or other downstream events were discounted. Consistent with the behavior of endogenous *MYC,* we observed increased CUG-initiated translation in *EIF5A*^−/−^ cells ([Figure 4B](#F4){ref-type="fig"}). This effect was driven by a specific increase in activity of CUG-initiated reporters and was not a normalization artifact due to altered activity of AUG-initiated reporters ([Figure S5A](#SD1){ref-type="supplementary-material"}). Mutating the PPA tripeptide motif in the *MYC* leader sequence to PAA partially reduced the enhanced CUG-initiated translation observed in *EIF5A*^−/−^ conditions. Moreover, a frameshift mutation that eliminated the PPA motif and altered the surrounding amino acids strongly impaired CUG-initiated translation. These data support the model that ribosomal pausing in the proximal segment of the *MYC* transcript in eIF5A-deficient cells promotes upstream translation initiation at the non-canonical MYC1 initiation codon. The behavior of the frameshifted reporter suggests that pausing in this region of the transcript is mediated not only by the PPA tripeptide motif but also by other N-terminal amino acids encoded in this sequence. This is in accordance with previous reports showing that amino acids upstream and downstream of pause sites, as well as amino acids within the nascent peptide chain in the exit channel of the ribosome, can influence the extent of ribosomal pausing ([@R7]; [@R63]).

Proximal Ribosomal Pausing Triggers Widespread Upstream Translation Initiation {#S8}
------------------------------------------------------------------------------

We next examined ribosome profiling data to determine whether proximal ribosomal pausing influences start codon selection more broadly throughout the transcriptome. Transcripts were segregated into two groups on the basis of their predicted behavior according to our pausing-associated upstream initiation model ([Figure 5A](#F5){ref-type="fig"}). Group 1 comprised genes that were predicted to show increased 5′ UTR translation in *EIF5A*^−/−^ cells, specifically genes whose transcripts contained a canonical (AUG) or non-canonical (any single nucleotide variant of AUG) initiation site upstream of the annotated start site and a downstream in-frame ribosomal pause site within 67 codons. This window was chosen because of evidence indicating that this was the maximal distance that allowed effective ribosome queuing-mediated effects on alternative translation initiation ([@R35]). All other genes that did not satisfy these criteria were placed into group 2. 5′ UTR translation in these transcripts under conditions of eIF5A or DOHH loss of function was then assessed.

We first defined group 1 transcripts as those containing a PP dipeptide, the minimal, classically studied eIF5A-associated pause motif, downstream of putative 5′ UTR initiation sites. Notably, of the 295 genes that showed at least a 2-fold increase in upstream translation in *EIF5A* knockout cells described above, 259 fulfilled these criteria and were classified as group 1. Consistent with the behavior of these 259 genes, group 1 transcripts exhibited an overall increase in 5′ UTR translation upon eIF5A and DOHH loss of function ([Figures 5B](#F5){ref-type="fig"} and [S5B](#SD1){ref-type="supplementary-material"}). We also detected an increase in upstream translation in *EIF5A*^−/−^ cells when we reclassified group 1 to comprise genes that contain an upstream initiation site followed by an in-frame pause site defined as any of the top 20 pause motifs identified in our *de novo* analysis ([Figures 2F](#F2){ref-type="fig"} and [5C](#F5){ref-type="fig"}). A similar trend was also documented in *DOHH*^−/−^ cells, although the effect did not reach statistical significance under these conditions ([Figure S5C](#SD1){ref-type="supplementary-material"}). Last, when this model was applied to yeast ribosome profiling data, similar effects were observed ([Figures 5D](#F5){ref-type="fig"} and [S5D](#SD1){ref-type="supplementary-material"}). Collectively, these data support the model that hypusine-modified eIF5A is required to suppress widespread proximal ribosomal pausing in order to maintain efficient scanning and accurate start codon selection, in a manner that is conserved in yeast and human cells.

DISCUSSION {#S9}
==========

Accumulating evidence from multiple tumor types has established that altered translational control plays an important role in cancer pathogenesis ([@R85]). This principle is exemplified by the growth-promoting mTOR pathway, which is activated in many malignancies and promotes translation of specific mRNAs through multiple mechanisms ([@R31]; [@R55]; [@R57]; [@R66]). For example, translation of *MYC* and other mRNAs whose 5′ UTRs contain complex secondary structures is stimulated by the mTOR pathway in response to growth factors, nutrients, and oncogenic signaling. Activity of the mTORC1 complex, through phosphorylation of its protein targets S6K and eIF4E-BPs, promotes the assembly of the cap-binding complex (comprising eIF4E, eIF4G, and eIF4A) and thus facilitates translation of difficult to translate messages, including *MYC*.

Given the importance of regulation of *MYC* expression at multiple post-transcriptional levels, including translational control, we performed an unbiased screen to identify new regulators of the *MYC* 5′ UTR. These experiments led to the discovery of an unexpected role for eIF5A as a regulator of start codon selection. In the case of the *MYC* transcript, eIF5A depletion triggered the enhanced production of the N-terminally extended MYC1 protein initiated at an upstream CUG start codon. Similar effects, specifically enhanced translation initiation at suboptimal or non-canonical initiation codons in 5′ UTRs, occurred broadly throughout the human and yeast transcriptomes under conditions of eIF5A loss of function. Ribosome profiling experiments demonstrated that the function of eIF5A as a suppressor of ribosomal pausing at difficult to translate peptide motifs is conserved in human cells and provided strong evidence that ribosomal pausing promotes the use of upstream initiation codons in eIF5A-deficient cells. These findings extend our understanding of the functions of this deeply conserved translation factor and uncover a role for eIF5A in maintaining the fidelity of translation initiation.

Reporter-coupled CRISPR/Cas9 screening represents a powerful approach for dissecting mechanisms of post-transcriptional gene regulation. This work was initiated with a genome-wide screen to interrogate regulators of the *MYC* 5′ UTR. Two important translation factors emerged from the screen: eIF3L and eIF5A. Our finding that eIF3L is a putative repressor of the *MYC* 5′ UTR is in line with reports suggesting that in addition to a general role for the large multi-subunit eIF3 complex in translation initiation, specialized eIF3 complexes may direct the translational repression of a subset of transcripts, such as *BTG1* ([@R45]). Although *EIF3L* knockout did not increase steady-state MYC protein levels in HCT116 cells, possibly because of multiple redundant levels of MYC regulation in this cell line, further examination of this putative regulatory interaction in other contexts remains an interesting direction for future work.

Loss of eIF5A, the top hit from our screen, resulted in enhanced EGFP fluorescence produced by the *MYC* 5′ UTR reporter but, unexpectedly, altered endogenous *MYC* translation initiation codon selection rather than increasing total MYC protein levels. As discussed above, these apparently discordant results may have arisen in part from differences in the requirement for eIF5A to facilitate translation elongation through the *EGFP* and *MYC* ORFs. The *MYC* coding sequence has six strong PP or PG ribosomal pause sites, while *EGFP* has none, suggesting that efficient translation through the *MYC* ORF may be highly dependent on eIF5A. Rather than further investigating the behavior of the reporter, however, we chose to focus on dissecting the role of this protein in regulating endogenous *MYC* and other transcripts. Ultimately, our transcriptome-wide analyses of eIF5A function not only allowed us to elucidate a role for eIF5A in translation initiation but also enabled the generation of new reporters that, unlike the *EGFP* reporter, accurately recapitulated the behavior of endogenous *MYC* ([Figure 4](#F4){ref-type="fig"}).

The established function of eIF5A, derived from an extensive body of work studying the yeast and bacterial orthologs, is to relieve ribosomal pausing at sites of inefficient peptide bond formation ([@R64]; [@R72]; [@R90]). Here we globally analyzed translation in human cells lacking this protein, demonstrating that this molecular function is conserved and supporting a role for eIF5A as a universal pause relief factor. We observed that hypusine-modified eIF5A alleviates ribosomal pausing primarily at PP and PG dipeptides in human cells. This generally agrees with previously identified pause signatures and is consistent with literature implicating these amino acids as suboptimal substrates for peptide bond formation ([@R16]; [@R62]; [@R63]; [@R64]; [@R72]; [@R79]). This functional conservation of eIF5A is a direct reflection of the remarkable degree to which the homologs of these proteins are conserved in sequence and structure across kingdoms ([@R15]; [@R51]). Notably, our data are also consistent with prior literature indicating that the hypusine modification is critical for eIF5A function ([@R8]; [@R71]).

Suppression of ribosomal pausing by eIF5A is necessary to maintain efficient translation elongation. Interestingly, it has been suggested that depletion of EF-P, the bacterial eIF5A ortholog, not only impairs elongation but also inhibits translation initiation on certain transcripts, specifically those harboring start codons located upstream of strong ribosomal pause sites ([@R90]). Ribosome queuing upstream of these pause sites was proposed to sterically block access of initiating ribosomes to start codons on these mRNAs. Our analysis of human and yeast eIF5A also supports a role for this protein in regulating translation initiation in an analogous manner. Unlike the data from bacterial systems, however, our findings suggest that ribosome queuing upstream of pause sites in eIF5A-depleted eukaryotic cells increases the use of suboptimal or non-canonical start codons in 5′ UTRs. This model is supported by the demonstration that sites of inefficient peptide bond formation, thermostable RNA structures, or pharmacologic agents that impede ribosomal elongation can similarly enhance translation initiation from AUG codons in suboptimal Kozak contexts or non-AUG codons in both viral ([@R89]) and endogenous transcripts ([@R35]; [@R38]; [@R42]; [@R48]). Taken together, the existing data from eukaryotic systems suggest that in the absence of eIF5A, stalled ribosomes in 5′ UTRs or proximal coding sequences lead to ribosome queuing, which impedes the efficient scanning of PICs before they reach downstream, optimal start codons (as illustrated by the *MYC* transcript in [Figure 4A](#F4){ref-type="fig"}). The subsequent increase in dwell time of these complexes in the 5′ UTR may increase the probability of translation initiation at upstream, non-optimal initiation codons.

Whether there is a physiologic role for enhanced upstream translation initiation triggered by proximal ribosomal pausing is an interesting question for future study. Analysis of yeast ribosome profiling data revealed a widespread increase in 5′ UTR translation across the transcriptome upon depletion of eIF5A, an effect that occurred on a more restricted set of human transcripts. Nevertheless, in both yeast and human cells, transcripts encoding mediators of the cellular stress response, which have been documented to harbor suboptimal or non-canonical translation initiation sites within their 5′ UTRs, exhibited a dependence on eIF5A for maintenance of appropriate translation initiation. Taken together with the fact that widespread and early (within 50--65 codons of initiation) ribosomal pausing has been documented under specific stress conditions ([@R49]; [@R78]), our data suggest that the mechanism of proximal pause-induced upstream initiation may be pervasively used to enhance translation of mRNAs encoding stress response factors.

Multiple lines of evidence also suggest the intriguing possibility that enhanced upstream translation initiation, caused by activation of the ISR or impaired eIF5A activity, may contribute to cancer pathogenesis. In a mouse model of squamous cell carcinoma, for example, elevated eIF2α phosphorylation, indicative of activation of the ISR, was associated with the use of an eIF2A-driven translational program that facilitated preferential translation of oncogenic mRNAs initiated from upstream start codons ([@R76]). eIF5A loss of function may trigger a similar effect in several human cancers. *EIF5A* is located within the frequently deleted human 17p locus that also contains the tumor suppressor *TP53.* Approximately 50% of all human cancers exhibit inactivation of *TP53,* and a majority of these malignancies contain at least one large 17p deletion, thus concurrently ablating *EIF5A.* The functional relevance of *TP53-EIF5A* co-deletion was substantiated by the demonstration that loss of function of *EIF5A*, or other members of the polyamine-hypusine pathway, accelerated MYC-driven lymphomagenesis in mice ([@R50]; [@R73]). Whether these effects are driven by enhanced production and oncogenic activity of MYC1 in this model, or the more widespread induction of ribosomal pausing and upstream translation, remains to be established. Additionally, it is important to note that overexpression of *EIF5A* has been observed in some tumor types ([@R86]), raising the possibility that more efficient suppression of ribosomal pausing, and potentially reduced production of MYC1, may be favored in some cancer contexts.

We have demonstrated that ribosomal pausing and increased upstream translation on *MYC* and other transcripts can be induced by depletion of total or hypusine-modified eIF5A. Thus, it also is likely that upstream signals that modulate cellular polyamine levels, and consequently levels of hypusine-modified eIF5A, can similarly influence alternative initiation. Polyamines---putrescine, spermidine, and spermine---are essential cations that, in addition to serving as obligate precursors for the production of hypusine, have myriad cellular functions that support the demands of cellular growth, including chromatin maintenance, scavenging of free radicals, and binding to ribosomal components to promote translation ([@R10]; [@R14]). Accordingly, oncogenic signaling can induce polyamine production, and MYC itself promotes transcription of several enzymes in the polyamine-biosynthesis pathway ([@R4]). Although modulation of cellular polyamine levels would be expected to have pleiotropic effects on cell growth and homeostasis, our findings reveal that start codon selection may be broadly affected under these conditions as well. Thus, the effect of polyamine availability on translational reprogramming through modulation of eIF5A activity is an interesting area for further investigation.

In conclusion, we have demonstrated that suppression of ribosomal pausing by eIF5A is a highly conserved function that is required not only to maintain efficient translation within ORFs but also to suppress the use of upstream initiation codons. These findings highlight the broad influence of ribosomal pausing on multiple steps of translation. Further study of the stimuli that cause an elongating ribosome to stall, including eIF5A-associated pause cues, as well as other triggers of pausing such as tRNA abundance and RNA secondary structure, will enable the dissection of subsequent effects on the transcriptome and proteome and the physiological contexts in which these mechanisms are used for gene regulation.

STAR★METHODS {#S10}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S11}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Joshua Mendell (<joshua.mendell@utsouthwestern.edu>). All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

Cell lines used in this study were obtained from ATCC and confirmed to be free of mycoplasma contamination. HCT116 cells (human) were cultured in McCoy's 5A medium supplemented with 10% fetal bovine serum (FBS) and 1X antibiotic/antimycotic (ThermoFisher). HEK293T cells (human) were cultured in DMEM supplemented with 10% FBS and 1X antibiotic/antimycotic. HCT116 is a male cell line and HEK293T is most likely female due to the presence of multiple X chromosomes and no detectable Y chromosome.

METHOD DETAILS {#S13}
--------------

### Construction of MYC-EGFP reporter constructs {#S14}

The sequences of all oligonucleotides used in this study are provided in [Table S3](#SD4){ref-type="supplementary-material"}. The following plasmids were obtained: AAVS1 hPGK-PuroR-pA donor (Addgene plasmid \#22072), pMSCV-Hygro (Clontech), and pEGFP-N1 (Clontech). First, PGK-Puro was excised from AAVS1 hPGK-PuroR-pA donor by HindIII digestion and replaced with PGK-Hygro (amplified from pMSCV-Hygro with primer pair HM284/HM285) using the In Fusion HD Cloning Kit (Takara) to generate the AAVS1-Donor-PGK-Hygro plasmid. During this cloning, FseI and MluI sites were introduced 5′ to the PGK promoter, and SalI, EcoRV and HindIII sites were introduced 3′ of the hygromycinB resistance gene. Next, a synthetic polyA signal ([@R75]) was synthesized, and inserted downstream of the hygromycinB resistance gene using the SalI and EcoRV sites. Third, the CMV-EGFP-SV40polyA cassette was amplified from pEGFP-N1 (using primer pair HM280/HM281) and cloned into the AAVS1-Donor-PGK-Hygro-pA plasmid using FseI and MluI sites, to generate the AAVS1-Donor-Hygro-EGFP plasmid. Lastly, the *EGFP* ORF was amplified (using the primer pair HM320/HM321) and cloned back into this vector (AAVS-Donor-Hygro-EGFP) using KpnI and XbaI sites to generate the final *EGFP* reporter donor vector (pAAVS-EGFP-DONOR). This was done to simplify in-frame cloning upstream of the *EGFP* ORF in this vector. The *MYC* 5′ UTR was amplified from human genomic DNA (using primers HM322/HM324) and cloned into pAAVS-EGFP-DONOR digested with KpnI using the In Fusion HD Cloning kit to generate the *MYC* 5′ UTR reporter donor plasmid (pAAVS-5′ UTR-DONOR). The complete sequence of the *MYC* 5′ UTR used in the reporter construct is provided in [Table S3](#SD4){ref-type="supplementary-material"}.

### Generation of clonal fluorescent reporter cell lines {#S15}

A published TALEN pair targeting the human *AAVS1/PPP1R12C* locus ([@R68]) was used, in combination with the either pAAVS1-EGFP-DONOR or pAAVS1--5′ UTR-DONOR, to generate *MYC* 5′ UTR reporter and *EGFP* reporter knock-in HCT116 cell lines. The three plasmids were transfected into HCT116 cells using FugeneHD transfection reagent (Promega), using the following molar ratio: Left TALEN:Right TALEN:Donor vector for homology-directed repair = 1:1:8. Two days post-transfection, the cells were split into 0.5 mg/mL hygromycinB (Thermofisher Scientific). The cells were selected for at least 7 days, before plating into 96-well plates at single cell density. Colonies arising from single cells were picked and expanded, and genomic DNA was extracted using the DNeasy Blood and Tissue Kit (QIAGEN). Clonal cell lines were then genotyped by PCR to detect the *AAVS1* wild-type and the *EGFP* knock-in alleles, using the primer pairs HM356/HM357 and HM356/HM359 respectively. Heterozygous knock-in clones were used for all experiments.

### Genome-wide CRISPR/Cas9 screening {#S16}

Fluorescent-reporter coupled CRISPR/Cas9-mediated loss-of-function screening was carried out as previously described in detail ([@R22]). A brief overview is provided here.

The human GeCKO v2 libraries A and B (Addgene pooled libraries \#\#1000000048, \#1000000049) were amplified in bacteria and purified, and then used to prepare lentivirus in HEK293T cells. Genome-wide screening was performed with libraries A and B in the *MYC* 5′ UTR and *EGFP* reporter cell lines, with two replicates for each cell line. Reporter cells were transduced with lentivirus at a multiplicity of infection between 0.2 -- 0.4. Two days later, the cells were seeded into 1 μg/mL puromycin to select for cells that had been successfully transduced. After passaging for 13 days in puromycin, cells were subjected to FACS on a MoFlo cell sorter (Beckman Coulter). The brightest 0.5% of cells were collected by FACS, pelleted, and frozen at −80°C.

sgRNA coverage was maintained at 500X during infection and at all subsequent stages of screening. 120 ×10^6^ cells were infected per library and at least 100 ×10^6^ cells were maintained per library during selection. 60--80 ×10^6^ cells were sorted per replicate per library, and 1.5 ×10^5^ -- 2.5 ×10^5^ cells were collected post sorting. 40 ×10^6^ unsorted cells were also pelleted and frozen at −80°C. Genomic DNA was extracted from the sorted and unsorted cell pellets using either a gDNA isolation method that has been previously described ([@R22]) for the sorted cells or the DNeasy Blood and Tissue Kit (QIAGEN) for the unsorted cells. Two sequential rounds of PCR were performed using the isolated genomic DNA as template to generate PCR amplicon libraries. Library DNA was then purified using Agencourt AMPure XP beads (Beckman Coulter Life Sciences). DNA concentration of the libraries was quantified by using the Qubit dsDNA BR Assay Kit (Thermofisher Scientific), as well as by qPCR using the KAPA Library Quantification Kit for Illumina platforms (Kapa Biosystems). Amplicon library size and integrity were also assessed via the Bioanalyzer High Sensitivity DNA Analysis Kit (Agilent). Following these quality checks, library amplicons were sequenced on an Illumina NextSeq500 with 75 bp single-end reads. Approximately 20 ×10^6^ reads were obtained per sample.

### Knockout of genes via lentiviral delivery of CRISPR/Cas9 components {#S17}

#### Generation of lentivirus {#S18}

sgRNAs targeting genes of interest, as well as non-target (NT) sgRNAs ([Table S3](#SD4){ref-type="supplementary-material"}), were cloned into the lentiCRISPRv2 (LCv2) vector (Addgene plasmid \#52961) according to the LCv2 cloning protocol ([@R77]). LCv2-sgRNA lentivirus was generated in HEK293T cells as follows: Cells were seeded at a density of 600,000 cells per well of a 6-well dish. The next day, cells were transfected with 0.5 μg LCv2-sgRNA plasmid, 0.3 μg psPAX2 (Addgene \#12260), and 0.2 μg pMD2.G (Addgene \#12259) lentiviral packaging plasmids using FugeneHD transfection reagent (Promega). Media was changed 24 hours post-transfection, and viral collection was performed on the two subsequent days. Media containing virus was filtered through a 0.45 μm SFCA sterile filter and either utilized immediately for transduction or frozen at −80°C in single use aliquots.

#### Infection of cells and generation of knockout pools {#S19}

Cells to be infected were seeded in an equal mix of fresh media and viral supernatant with polybrene (EMD Millipore) at a final concentration of 8 μg/ml. Cells were infected at densities such that they achieved confluency 48 hours post-transduction. Media was changed the day after infection and cells were split into media containing puromycin at a concentration of 1 μg/ml 48 hours after infection.

For all experiments using *EIF5A*^−/−^ and *DOHH*^−/−^ pools, cells transduced with the appropriate LCv2-sgRNA virus were harvested for analysis after 6 days of selection in puromycin. Control pools used in these experiments were cells transduced with LCv2-NT sgRNA virus, selected in puromycin for 6 days and harvested in the same manner as *EIF5A*^−/−^ and *DOHH*^−/−^ knockout pools.

### Genome editing of the MYC1 initiation codon {#S20}

#### Generation of MYC1 knockout pools and siRNA transfection {#S21}

HCT116 cells were infected with lentiCRISPRv2 virus selectively targeting MYC1 (sgRNA sequence listed in [Table S3](#SD4){ref-type="supplementary-material"}) and selected in puromycin as described above. On the third day of selection, cells infected with MYC1 sgRNA and NT sgRNA were reverse transfected with siRNA (either targeting *EIF5A,* or NT controls listed in [Table S3](#SD4){ref-type="supplementary-material"}, Dharmacon) at a concentration of 20 nM, using Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to the manufacturer's instructions. Cells were harvested for gDNA isolation and western blot analysis at 72 hours post-transfection of siRNA (corresponding to 6 days of puromycin selection).

#### Genotyping of MYC1-sgRNA targeting site by next-generation sequencing {#S22}

Cells infected with lentiCRISPR-MYC1 sgRNA or lentiCRISPR-NT sgRNA and then transfected with NT siRNA were harvested for genomic DNA isolation using the DNeasy Blood and Tissue Kit (QIAGEN). Amplicon libraries (of the sgRNA target site) were generated by two sequential rounds of PCR using Phusion High-Fidelity DNA Polymerase (NEB). PCR1 was performed using gene specific primers HM685/HM686, and PCR2 was performed using Illumina TruSeq CD Indexes D508 (Fwd)/D706--709 (Rev). Amplicons were sequenced using a MiSeq instrument with at least 100,000 reads per sample.

### Western blot analysis {#S23}

Cell lysates were prepared by harvesting in ice cold 1X RIPA buffer. Proteins were visualized and signals were quantified using an infrared fluorescent antibody detection system (LI-COR). Blocking was performed in 10% BSA for phospho-antibodies or 10% non-fat milk for all other antibodies. Primary antibodies were utilized at a concentration of 1:1000, diluted in 5% BSA in TBST (for phospho-antibodies) or 5% non-fat milk in TBST (for all other antibodies), and are listed in the [Key Resources table](#T1){ref-type="table"}.

### RNA isolation and qRT-PCR {#S24}

Cells at subconfluent densities were harvested in Trizol (Thermo Fisher Scientific). RNA was isolated using the Direct-zol RNA miniprep kit (Zymoresearch). The on-column DNase digestion step was performed according to manufacturer's instructions. SuperScript III First-strand Synthesis SuperMix (Thermo Fisher Scientific) was used to synthesize cDNA from RNA, using 1 μg of RNA per reaction. All qPCR assays were performed in technical triplicate, using the SybrGreen 2X PCR Master Mix (Applied Biosystems). Primers used for qRT-PCR are listed in [Table S3](#SD4){ref-type="supplementary-material"}.

### Ribosome profiling {#S25}

HCT116 cells were transduced with lentiCRISPRv2 virus targeting *EIF5A* or *DOHH,* or expressing NT sgRNA, and selected for 6 days in puromycin as described above to generate knockout pools. Cells were harvested and ribosome profiling was performed exactly as described ([@R52]), with the following modifications:

1.  Ribosome footprints were size selected by gel electrophoresis as described previously ([@R34]), and fragments between 24--35nt were excised for library preparation.

2.  Samples were not pooled after linker ligation, and the subsequent steps were performed individually for each sample.

3.  In order to effectively separate 3′ linker-ligated RNA fragments from unligated linker, we utilized gel electrophoresis, followed by gel extraction as previously described ([@R34]), instead of an enzymatic depletion.

### Arsenite treatment {#S26}

800,000 HCT116 cells were seeded in each well of a 6-well dish. The following day, the cells were treated with 250 μM sodium arsenite for up to 3 hours. Cells were then harvested and analyzed by western blotting as described above.

### Luciferase reporter assays {#S27}

#### Construction of luciferase reporters {#S28}

The firefly luciferase ORF in pGL3-Control (Promega) was first modified to remove N-terminal/proximal pause sites. A proline-glycine dipeptide (aa 37--38) and a proline-proline dipeptide (aa 173--174) were mutated to proline-alanine using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent) and the primer pairs HM673/HM674 and HM677/HM678, respectively, to generate pGL3-Control_NP2. *MYC* 5′ UTR reporter fragments were then cloned into the HindIII and NcoI sites in pGL3-Control_NP2 using the NEBuilder HiFi DNA Assembly Master Mix (NEB). The *MYC* 5′ UTR reporter fragments used in the assembly were designed to contain a fragment of the *MYC* transcript beginning 15 nt upstream of the MYC1 CUG initiation codon and extending 201 nt downstream of the MYC2 AUG initiation codon into the main *MYC* ORF (as depicted in [Figure 4B](#F4){ref-type="fig"}), followed by a P2A sequence. The MYC2 initiation codon was mutated from AUG to a non-initiating UUU in all constructs. The frameshifted reporter was generated by introducing a single nucleotide deletion 6 aa upstream of the PPA pause motif. Appropriate homology arms to facilitate HiFi assembly were added and fragments were obtained as gBlocks synthesized by IDT (sequences provided in [Table S3](#SD4){ref-type="supplementary-material"}).

*PLOD3* 5′ UTR luciferase reporter constructs were designed and constructed in a manner similar to the *MYC* 5′ UTR luciferase reporters. Fragments of the *PLOD3* transcript containing the entire *PLOD3* 5′ UTR and a small segment of the ORF were synthesized as gene fragments and cloned into a plasmid vector by Genewiz (sequences provided in [Table S3](#SD4){ref-type="supplementary-material"}). Synthesized fragments were then amplified using primers that added a left homology arm, and a P2A element and a homology arm on the right to facilitate cloning into pGL3-Control_NP2 using the NEBuilder HiFi DNA Assembly Master Mix (NEB) at HindIII and NcoI sites, as described above. Three *PLOD3* constructs that each reported translation in a different reading frame were generated by synthesizing segments of the *PLOD3* transcript that differed in length by one nucleotide (the first 498, 499, or 500 nucleotides of the transcript) and fusing them to the P2A-luciferase cassette. In each reporter, all stop codons contained within the *PLOD3* transcript segments that were in the same reading frame as the luciferase ORF were mutated to alanine codons to ensure productive read out of translation. Further, the AUG start codon (contained in the Frame 1 construct) was mutated to the non-initiating UUU. Lastly, a luciferase reporter containing the unaltered AUG start codon (and similar to the Frame 1 reporter in all other respects) was generated to use as a control to monitor canonical AUG translation. Primers used for amplifying the *PLOD3* fragments were as follows (sequences provided in [Table S3](#SD4){ref-type="supplementary-material"}): Frame 1 -- HM705/HM706; Frame 2 -- HM705/HM707; Frame 3 -- HM705/HM710; ATG-Control -- HM705/HM706.)

#### Dual luciferase reporter assays {#S29}

HCT116 cells were infected with lentiCRISPRv2 virus containing *EIF5A*-targeting or NT sgRNAs as described above. On the fourth day of selection in puromycin, cells were plated in 24-well dishes at densities such that they would be 50% confluent in 24 hours. The following day, cells were transfected with luciferase reporters using FugeneHD transfection reagent (Promega). 300 ng of DNA was transfected/well, comprising 2 ng of pRL-SV40 (Promega) as a transfection control, 198 ng of empty pcDNA3.1(+) (Invitrogen), and 100 ng of a pGL3--5′ UTR reporter. Cells were harvested 24 hours later and luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S30}
---------------------------------------

### Analysis of genome-scale CRISPR/Cas9 screening data {#S31}

The GeCKO v2 library sgRNA reference files were obtained from Addgene and identical sgRNAs targeting more than one gene were removed. Bowtie 2 was used to map reads obtained from the demultiplexed FASTQ files to the modified reference library, allowing no mismatches, and normalized read counts were calculated as described previously ([@R77]). MAGeCK was used to identify statistically significant hits from the screening data ([@R46]). We detected contaminating reads in the library corresponding to sgRNAs targeting *NFE2L2* (arising from cloning of individual sgRNAs into the LCv2 vector) and this gene was therefore removed from our analysis.

### Bioinformatic analysis of ribosome profiling data {#S32}

#### Read preparation and mapping {#S33}

For analysis of reads from the human ribosome profiling dataset, reads from two separate sequencing runs for each sample were first combined. Next, the adaptor, inline barcode, and the random-mer incorporated into the library amplicon were trimmed for each read. Then, reads from noncoding RNAs were removed by mapping to known rRNA ([@R65]), tRNA ([@R11]), and snRNA ([@R43]) sequences using HISAT2 ([@R41]). Reads that did not map to these databases were subsequently mapped to the human reference genome (GRCh38) ([@R19]) using HISAT2. Reads with lengths between 24 -- 31 nt were used for all analyses. Annotation of transcripts was based on GENCODE v27 ([@R19]) and for each gene with multiple isoforms, the longest transcript was used.

Reads from yeast ribosome profiling data were processed as follows: First, the adaptor was trimmed for each read. Reads with quality score less than 20 at any position or that mapped to known noncoding RNAs were removed. The remaining reads were then mapped to the yeast reference genome ([@R17]) using HISAT2. Only reads between 25 -- 34 nt were used for subsequent analyses. Annotation of transcripts was based on a published dataset ([@R56]).

#### Periodicity analysis ([Figure S3](#SD1){ref-type="supplementary-material"}) {#S34}

For each mapped read in the human dataset, the codon occupying the P-site of the ribosome was defined as nucleotides 13--15 from the 5′ end of the mapped read. This offset length was calculated by identifying the modal distance between the 5′ end of reads mapped to annotated translation start sites and the corresponding AUG start codons. Ribosome occupancy at each position was calculated by determining the number of reads whose 5′ ends mapped 12 nt upstream, and thus represented P-site occupancy of the ribosome in all analyses. The numbers of reads at each position (corresponding to P-site ribosome occupancy at that position) were normalized to the total number of mapped reads per sample (in millions) to yield reads per million mapped reads (RPM). Normalized read counts (RPM) at each position were aggregated across all transcripts to generate periodicity plots.

#### Meta-codon plots ([Figures 2C](#F2){ref-type="fig"} and [2G](#F2){ref-type="fig"}) {#S35}

Proline-proline (PP) motifs from all coding sequence (CDS) regions were considered, and those with another PP motif located within 50 nt upstream were discarded. RPM values were aggregated at each position within a 100 nt region centered on PP motifs and the values at the first nucleotide of each codon (corresponding to in-frame reads) were plotted.

A similar analysis was performed to generate a meta-codon plot centered on the top 20 tripeptide pause motifs in *EIF5A*^−/−^ cells compared to sgNT. Identification of those tripeptides is described below.

#### Pause motif analysis ([Figures 2D](#F2){ref-type="fig"}--[2F](#F2){ref-type="fig"}) {#S36}

Genes whose CDS fulfilled a minimum coverage requirement of at least 128 reads in each replicate of each sample were used in this analysis of human ribosome profiling data. The first 100 nt and the last 100 nt of the CDS were excluded from consideration in pause motif calculations. The ratio of average ribosome occupancy at each codon triplet (tripeptide motif) to average ribosome occupancy of the CDS was calculated and defined as the pause score. The average pause score for each tripeptide motif across all considered CDSs was calculated. Tripeptides that occurred \> 50 times in the considered CDSs, and whose average pause score in *EIF5A*^−/−^ samples was \> 3 in both replicates (listed in [Figure 2F](#F2){ref-type="fig"}) were used to construct a position weighted matrix, where tripeptides were weighted by the ratio of their average pause score in *EIF5A*^−/−^ to sgNT. An identical analysis was performed to identify a tripeptide pause motif signature in *DOHH*^−/−^ cells.

#### CDF plots ([Figures 2A](#F2){ref-type="fig"}, [2B](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"}, [3C](#F3){ref-type="fig"}, [S4B](#SD1){ref-type="supplementary-material"}, [5B](#F5){ref-type="fig"}--[5D](#F5){ref-type="fig"}, and [S5B](#SD1){ref-type="supplementary-material"}--[S5D](#SD1){ref-type="supplementary-material"}) {#S37}

For reads obtained from yeast ribosome profiling data, the 15^th^ nucleotide from the 3′ end was defined as the first nucleotide of the P-site codon (offset calculated from reads mapping to annotated start codons, as described above). For both human and yeast datasets, reads were assigned to the 5′ UTR or CDS based on the location of the calculated P-site. Reads whose P-site mapped 3 nt upstream or downstream of the start codon were not utilized for these analyses. Reads per kilobase per million mapped reads, or RPKM, was used to represent ribosome occupancy of a 5′ UTR or CDS.

For CDF plots generated from human ribosome profiling data comparing *EIF5A*^−/−^ to sgNT, genes that were covered by at least 128 reads in the RNA-seq experiment in both sgNT or in both *EIF5A*^−/−^ samples, and that additionally fulfilled the following coverage criteria were used in the analysis: For plots calculating CDS ribosome occupancy, genes covered by at least 128 reads in the CDS in both sgNT samples or in both *EIF5A*^−/−^ samples were included. For CDF plots calculating 5′ UTR translation, genes whose 5′ UTRs were covered by at least 16 reads in both sgNT samples or in both *EIF5A*^−/−^ samples were included. Similar coverage requirements were applied when comparing *DOHH*^−/−^ to sgNT samples. For CDF plots comparing *EIF5A* knockdown (KD) to WT yeast, genes whose CDS was covered by at least 64 reads in both WT or in both *EIF5A* KD samples, and genes whose 5′ UTRs were covered by at least 6 reads in both WT or both *EIF5A* KD samples were included.

DATA AND CODE AVAILABILITY {#S38}
--------------------------

All high-throughput sequencing data generated in this study (CRISPR screening, RNA-seq, and ribosome profiling) have been deposited in GEO under accession GEO: GSE132010.
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![A Genome-Scale Loss-of-Function Screen Identifies eIF5A as a Regulator of *MYC* Translation Initiation Codon Selection\
(A) Schematic of reporter constructs and CRISPR/Cas9 screening strategy.\
(B) Flow cytometry analysis of EGFP fluorescence of reporter cell lines.\
(C) Representative western blot analysis of HCT116 cells following lentiviral delivery of Cas9 and the indicated sgRNAs. In this and all subsequent western blots, α-TUB is included as a loading control. NT, non-targeting control sgRNA.\
(D) Quantification of MYC1 protein relative to TUB (upper) or MYC1 relative to MYC2 (lower) from western blots after delivery of the indicated sgRNAs (n = 3 biological replicates, including blots shown in C).\
(E) Schematic of the human *MYC* transcript.\
(F) Western blot analysis of HCT116 cells following lentiviral delivery of Cas9 and the indicated sgRNAs. Hyp-eIF5A, hypusine-modified eIF5A.\
(G) Quantification of MYC1 protein relative to TUB (upper) or MYC1 relative to MYC2 (lower) from western blots after delivery of the indicated sgRNAs (n = 3 biological replicates, including blots shown in F).\
Error bars represent SD. \*p \< 0.05 and \*\*\*p \< 0.001, calculated using two-tailed t test. See also [Figures S1](#SD1){ref-type="supplementary-material"} and [S2](#SD1){ref-type="supplementary-material"}.](nihms-1545830-f0002){#F1}

![eIF5A Relieves Ribosomal Pausing at PP and PG Dipeptides during Translation Elongation in Human Cells\
(A and B) Cumulative distribution function (CDF) plots of coding sequence (CDS) ribosome occupancy on transcripts that have either ≤1 or \>1 PP dipeptide in their ORF in *EIF5A*^−/−^ (A) or *DOHH*^−/−^\
(B) cells relative to cells expressing non-target (NT) sgRNA. CDS occupancy is defined as ribosome occupancy in CDS (RPKM) normalized to transcript expression level derived from RNA-seq (FPKM). Number of genes in the analysis (that fulfilled minimum coverage criteria; see [STAR Methods](#S10){ref-type="sec"}): in (A), 2,467 (≤1 PP) and 2,309 (\> 1 PP); in (B), 2,597 (≤1PP) and 2,482 (\>1 PP). p values for this and all subsequent CDF plots were calculated using one-sided Kolmogorov-Smirnov tests.\
(C) Meta-codon plot of ribosome occupancy in a 100 nt window surrounding all PP dipeptides (28,571 total) in *EIF5A*^−/−^, *DOHH*^−/−^, and control sgNT cells. Mean ribosome occupancy of two biological replicates is shown.\
(D and E) Motif analysis of amino acid enrichment within the E, P, and A sites of paused ribosomes in *EIF5A*^−/−^ (D) and *DOHH*^−/−^ (E) cells, compared with sgNT control cells.\
(F) Top tripeptide pause motifs identified in *EIF5A*^−/−^ cells (having pause scores \> 3 and ranked by ratio of pause score in *EIF5A*^−/−^ versus sgNT). PP/PG-containing tripeptides are indicated with red text. Ribosome pause sites identified in both *EIF5A*^−/−^ and *DOHH*^−/−^ cells are shaded gray.\
(G) Meta-codon plot of ribosome occupancy in a 100 nt window surrounding the top 20 tripeptide pause motifs in *EIF5A*^−/−^ cells compared with sgNT (32,856 total). Mean ribosome occupancy of two biological replicates is shown.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1545830-f0003){#F2}

![Loss of Function of eIF5A Increases Upstream Translation Initiation\
(A) CDF plot of 5′ UTR translation in *EIF5A* knockdown (KD) and wild-type (WT) yeast. 5′ UTR translation defined as normalized ribosome occupancy (RPKM) in 5′ UTR/CDS (1,338 genes included on the basis of minimal coverage criteria). Data for this and all subsequent yeast analyses are from [@R72].\
(B) Ribosome occupancy on the yeast *GCN4* transcript in *EIF5A* KD and WT yeast. Region of upstream translation is marked with an asterisk. Previously reported uORFs are denoted by gray boxes ([@R92]).\
(C) CDF plot of 5′ UTR translation in *EIF5A*^−/−^ and control sgNT HCT116 cells. 5′ UTR translation is defined as ribosome occupancy (RPKM) in 5′ UTR normalized to transcript expression level derived from RNA sequencing (RNA-seq) (FPKM; 3,447 genes included on the basis of minimal coverage criteria).\
(D and E) Ribosome occupancy on the human *MYC* (D) and *PLOD3* (E) transcripts in *EIF5A*^−/−^, *DOHH*^−/−^, and control sgNT cells. Region of upstream translation is marked with an asterisk.\
(F) *PLOD3* reporter constructs used for luciferase assays, consisting of the *PLOD3* 5′ UTR and beginning of the *PLOD3* ORF fused to a P2A-luciferase sequence (left). Because the *PLOD3* 5′ UTR has multiple potential upstream initiation codons in all three reading frames, the P2A-luciferase sequence was fused in all three reading frames, with all upstream stop codons removed. Following transfection of reporters into *EIF5A*^−/−^ or control (sgNT-infected) HCT116 cells, upstream translation was calculated by first normalizing firefly luciferase activity to co-transfected renilla luciferase and then normalizing to activity produced by a construct with the canonical *PLOD3* AUG-initiation codon. Data are represented as mean ± SD (n = 6 biological replicates). \*\*p \< 0.001 and \*\*\*p \< 0.00001, calculated using two-tailed Welch's t test.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}, [Table S1](#SD2){ref-type="supplementary-material"}, and [Table S2](#SD3){ref-type="supplementary-material"}.](nihms-1545830-f0004){#F3}

![Ribosomal Pausing Promotes Increased Use of the MYC1 Initiation Codon\
(A) Model of ribosome pause-induced upstream initiation on the *MYC* transcript. Enhanced pausing at the PPA tripeptide motif within the *MYC* leader in *EIF5A*^−/−^ cells may lead to queuing of scanning ribosomes upstream, thereby promoting increased use of the MYC1 initiation codon.\
(B) *MYC* reporter constructs used for luciferase assays, consisting of a 5′ segment of the *MYC* transcript fused to a P2A-luciferase sequence (left). The frameshift (F/S) reporter was constructed by deleting a single nucleotide six codons upstream of the PPA pause motif, thus altering all encoded amino acids downstream until the P2A sequence. Following transfection of reporters into *EIF5A*^−/−^ or control (sgNT-infected) HCT116 cells, CUG-initiated translation was calculated by first normalizing firefly luciferase activity to co-transfected renilla luciferase and then normalizing to activity produced by an otherwise identical AUG-initiated construct. Data are represented as mean ± SD (n = 6 biological replicates). \*\*p \< 0.001 and \*\*\*p \< 0.00001, calculated using two-tailed Welch's t test.\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1545830-f0005){#F4}

![Proximal Ribosomal Pausing Triggers Widespread Upstream Translation Initiation\
(A) Genes were classified into those that contained an upstream AUG or single-nucleotide variant thereof within 67 codons of an in-frame pause site (group 1) and all others (group 2).\
(B and C) CDF plots of 5′ UTR translation in *EIF5A*^−/−^ cells compared with sgNT control, with pause sites defined as PP dipeptides (B) or the top 20 tripeptide pause motifs identified in *EIF5A*^−/−^ cells compared to sgNT control (C). 5′ UTR translation was defined as ribosome occupancy (RPKM) in 5′ UTR normalized to transcript expression level derived from RNA-seq (FPKM). Genes included on the basis of minimal coverage requirements: 2,877 in group 1 and 570 in group 2 for (B) and 2,860 in group 1 and 587 in group 2 for (C).\
(D) CDF plot of 5′ UTR translation in *EIF5A* KD yeast compared with WT. Pause sites defined as PP dipeptides. 5′ UTR translation was defined as normalized ribosome occupancy (RPKM) in 5′ UTR/CDS. One hundred forty-nine genes were included in group 1 and 1,189 genes were included in group 2 on the basis of minimal coverage criteria.\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1545830-f0006){#F5}
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###### Highlights

-   A CRISPR screen reveals that eIF5A regulates start codon selection on *MYC* mRNA

-   Ribosome profiling demonstrates that eIF5A suppresses ribosomal pausing in human cells

-   Loss of eIF5A causes widespread translation initiation in 5′ UTRs in human and yeast

-   Ribosomal pausing in eIF5A-deficient cells promotes upstream translation initiation
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